SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-186983
Filing Date
2010-08-12
Accepted
2010-08-12 12:52:52
Documents
4
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 268998
2 CERTIFICATION OF ANTONIUS SCHUH, PH.D., PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 7359
3 CERTIFICATION OF RICHARD GLENN VINCENT, PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 6604
4 CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 dex321.htm EX-32.1 7972
  Complete submission text file 0001193125-10-186983.txt   292461
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52228 | Film No.: 101010356
SIC: 6770 Blank Checks